Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registry

References

• Merola JF, Qureshi A, Husni ME. Underdiagnosed and undertreated psoriasis: nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails. Dermatol Ther. 2018;31(3):1. doi: 10.1111/dth.12589
   Web of Science ®Google Scholar
• Egeberg A, See K, Garrelts A, et al. Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort. BMC Dermatol. 2020;20(1):3. doi: 10.1186/s12895-020-00099-7.
   PubMed Web of Science ®Google Scholar
• Helmick CG, Lee-Han H, Hirsch SC, et al. Prevalence of psoriasis among adults in the U.S.: 2003–2006 and 2009–2010 national health and nutrition examination surveys. Am J Prev Med. 2014;47(1):37–8. doi: 10.1016/j.amepre.2014.02.012.
   PubMed Web of Science ®Google Scholar
• Kivelevitch D, Frieder J, Watson I, et al. Pharmacotherapeutic approaches for treating psoriasis in difficult-to-treat areas. Expert Opin Pharmacother. 2018;19(6):561–575. doi: 10.1080/14656566.2018.1448788.
   PubMed Web of Science ®Google Scholar
• Lanna C, Galluzzi C, Zangrilli A, et al. Psoriasis in difficult to treat areas: treatment role in improving health-related quality of life and perception of the disease stigma. J Dermatolog Treat. 2022;33(1):531–534. doi: 10.1080/09546634.2020.1770175.
   PubMed Web of Science ®Google Scholar
• Lanna C, Zangrilli A, Bavetta M, et al. Efficacy and safety of adalimumab in difficult-to-treat psoriasis. Dermatol Ther. 2020;33(3):e13374. doi: 10.1111/dth.13374.
   PubMed Web of Science ®Google Scholar
• Aldredge LM, Higham RC. Manifestations and management of difficult-to-treat psoriasis. J Dermatol Nurses’ Assoc. 2018;10(4):189–197. doi: 10.1097/JDN.0000000000000418.
   Web of Science ®Google Scholar
• Strober B, Ryan C, van de Kerkhof P, et al. Recategorization of psoriasis severity: delphi consensus from the international psoriasis council. J Am Acad Dermatol. 2020;82(1):117–122. doi: 10.1016/j.jaad.2019.08.026.
   PubMed Web of Science ®Google Scholar
• Volpicelli Leonard K, Robertson C, Bhowmick A, et al. Perceived treatment satisfaction and effectiveness facilitators among patients with chronic health conditions: a self-reported survey. Interact J Med Res. 2020;9(1):e13029. doi: 10.2196/13029.
   PubMed Web of Science ®Google Scholar
• Wu JJ, Schrader A, McLean RR, et al. Improvement in body surface area is associated with better quality of life among patients with psoriasis in the corrona psoriasis registry. J Am Acad Dermatol. 2021;84(6):1715–1717. doi: 10.1016/j.jaad.2020.08.039.
   PubMed Web of Science ®Google Scholar
• Korman NJ, Malatestinic W, Goldblum OM, et al. Assessment of the benefit of achieving complete versus almost complete skin clearance in psoriasis: a patient’s perspective. J Dermatolog Treat. 2022;33(2):733–739. doi: 10.1080/09546634.2020.1772454.
   PubMed Web of Science ®Google Scholar
• Jorge MFS, Sousa TD, Pollo CF, et al. Dimensionality and psychometric analysis of DLQI in a Brazilian population. Health Qual Life Outcomes. 2020;18(1):268. doi: 10.1186/s12955-020-01523-9.
   PubMed Web of Science ®Google Scholar
• Strand V, Boers M, Idzerda L, et al. It’s good to feel better but it’s better to feel good and even better to feel good as soon as possible for as long as possible. Response criteria and the importance of change at OMERACT 10. J Rheumatol. 2011;38(8):1720–1727. doi: 10.3899/jrheum.110392.
   PubMed Web of Science ®Google Scholar
• Zhang W, Bansback N, Boonen A, et al. Validity of the work productivity and activity impairment questionnaire–general health version in patients with rheumatoid arthritis. Arthritis Res Ther. 2010;12(5):R177. doi: 10.1186/ar3141.
   PubMed Web of Science ®Google Scholar
• Basra MK, Salek MS, Camilleri L, et al. Determining the minimal clinically important difference and responsiveness of the dermatology life quality index (DLQI): further data. Dermatology. 2015;230(1):27–33. doi: 10.1159/000365390.
   PubMed Web of Science ®Google Scholar
• Sampogna F, Linder D, Piaserico S, et al. Quality of life assessment of patients with scalp dermatitis using the Italian version of the scalpdex. Acta Derm Venereol. 2014;94(4):411–414. doi: 10.2340/00015555-1731.
   PubMed Web of Science ®Google Scholar
• Hawro M, Maurer M, Weller K, et al. Lesions on the back of hands and female gender predispose to stigmatization in patients with psoriasis. J Am Acad Dermatol. 2017;76(4):648–654 e2. doi: 10.1016/j.jaad.2016.10.040.
   PubMed Web of Science ®Google Scholar
• Prevezas C, Katoulis AC, Papadavid E, et al. Short-term correlation of the psoriasis area severity index, the nail psoriasis area severity index, and the dermatology life quality index, before and after treatment, in patients with skin and nail psoriasis. Skin Appendage Disord. 2019;5(6):344–349. doi: 10.1159/000499348.
   PubMed Web of Science ®Google Scholar
• Horn EJ, Fox KM, Patel V, et al. Association of patient-reported psoriasis severity with income and employment. J Am Acad Dermatol. 2007;57(6):963–971. doi: 10.1016/j.jaad.2007.07.023.
   PubMed Web of Science ®Google Scholar
• Lewis-Beck C, Abouzaid S, Xie L, et al. Analysis of the relationship between psoriasis symptom severity and quality of life, work productivity, and activity impairment among patients with moderate-to-severe psoriasis using structural equation modeling. Patient Prefer Adherence. 2013;7:199–205. doi: 10.2147/PPA.S39887.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Saeki H, Ito T, et al. Impact of disease severity on work productivity and activity impairment in Japanese patients with psoriasis. J Dermatol Sci. 2013;72(2):188–191. doi: 10.1016/j.jdermsci.2013.06.003.
   PubMed Web of Science ®Google Scholar
• Villacorta R, Teeple A, Lee S, et al. A multinational assessment of work-related productivity loss and indirect costs from a survey of patients with psoriasis. Br J Dermatol. 2020;183(3):548–558. doi: 10.1111/bjd.18798.
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Siegel MP, Bagel J, et al. From the medical board of the national psoriasis foundation: treatment targets for plaque psoriasis. J Am Acad Dermatol. 2017;76(2):290–298. doi: 10.1016/j.jaad.2016.10.017.
   PubMed Web of Science ®Google Scholar